Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Liposome and Cisplatin in Metastatic Esophageal Cancer
NCT01998347Phase 3Withdrawn
- Sponsor
- Shantou University Medical College
- Start
- Nov 2013
- Primary completion
- Dec 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal paclitaxel in esophageal cancer, sponsored by Shantou University Medical College. Planned start Nov 2013; status: withdrawn.
02
Drugs
liposomal paclitaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT01998347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01998347.